Bank of America Corp
Change company Symbol lookup
Select an option...
BAC Bank of America Corp
CIHHF China Merchants Bank Co Ltd
BBY Best Buy Co Inc
BDGE Bridge Bancorp Inc
FFIC Flushing Financial Corp
TSC TriState Capital Holdings Inc
CSQPF Cervus Equipment Corp
IMXI International Money Express Inc
MDCO Medicines Co
TVETF Traverse Energy Ltd
Go

Financials : Banks | Large Cap ValueCompany profile

Bank of America Corporation is a bank holding company and a financial holding company. The Company is a financial institution, serving individual consumers and others with a range of banking, investing, asset management and other financial and risk management products and services. The Company, through its banking and various non-bank subsidiaries, throughout the United States and in international markets, provides a range of banking and non-bank financial services and products through four business segments: Consumer Banking, which comprises Deposits and Consumer Lending; Global Wealth & Investment Management, which consists of two primary businesses: Merrill Lynch Global Wealth Management and U.S. Trust, Bank of America Private Wealth Management; Global Banking, which provides a range of lending-related products and services; Global Markets, which offers sales and trading services, and All Other, which consists of equity investments, residual expense allocations and other.

Price
Delayed
$28.23
Day's Change
-0.415 (-1.45%)
Bid
--
Ask
--
B/A Size
--
Day's High
28.60
Day's Low
28.04
Volume
(Heavy Day)

Today's volume of 64,378,198 shares is on pace to be much greater than BAC's 10-day average volume of 54,789,083 shares.

64,378,198

Valens GroWorks a rare gainer in cannabis sector after inking extraction deal with Canopy Growth

1:51 pm ET December 13, 2018 (MarketWatch)
Print

Canada's Valens GroWorks Corp. shares were a standout in a mostly lower cannabis sector on Thursday, climbing 6% after news of an extraction agreement with Canopy Growth Corp. (WEED.T). Under the terms of the multi-year deal, Valens will use its proprietary technology to process whole flower and trim into high-grade cannabis resin for Canopy. The first shipment for processing is expected to arrive by year-end. Valens is expecting to have its first batch of branded products available through Canopy's sales channels for medical and recreational cannabis by the end of March 2019. Valens shares are up 32% in the month to date, while the S&P 500 has fallen 4%. Canopy shares were down 4% Thursday, and have fallen about 9% in the month to date.

-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

December 13, 2018 13:51 ET (18:51 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.